Altimmune

$2.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (4.65%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Altimmune and other stocks, options, ETFs, and crypto commission-free!

About ALT

Altimmune, Inc. Common Stock, also called Altimmune, is a clinical stage immunotherapeutic biotechnology company, which is focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Read More Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Employees
27
Headquarters
Gaithersburg, Maryland
Founded
1997
Market Cap
34.51M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
129.49K
High Today
$2.25
Low Today
$2.16
Open Price
$2.17
Volume
76.44K
52 Week High
$36.25
52 Week Low
$1.70

Collections

ALT Earnings

-$1.73
-$1.18
-$0.63
-$0.08
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 12, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.